A detailed history of Cascade Financial Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cascade Financial Partners, LLC holds 2,605 shares of NVO stock, worth $272,378. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,605
Previous 3,801 31.47%
Holding current value
$272,378
Previous $543 Million 44.08%
% of portfolio
0.04%
Previous 0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $142,407 - $173,922
-1,196 Reduced 31.47%
2,605 $303 Million
Q2 2024

Jul 31, 2024

BUY
$122.71 - $146.91 $10,307 - $12,340
84 Added 2.26%
3,801 $543 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $379,542 - $505,214
3,717 New
3,717 $463 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cascade Financial Partners, LLC Portfolio

Follow Cascade Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cascade Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cascade Financial Partners, LLC with notifications on news.